Budapest, Hungary

András Egyed



Average Co-Inventor Count = 14.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2005-2011

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: András Egyed: Innovator in Pharmaceutical Chemistry

Introduction

András Egyed is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 4 patents to his name, his work focuses on improving treatments for various disorders.

Latest Patents

Egyed's latest patents include innovative piperazine derivatives of alkyl oxindoles. This invention is concerned with new indol-2-one derivatives that exhibit a favorable activity profile for the prophylaxis and treatment of disorders in the central nervous and cardiovascular systems. Another significant patent involves piperazine derivatives of dialkyl oxindoles, which are new 3,3-disubstituted indol-2-one derivatives. These compounds are designed to be useful in treating or preventing diseases affecting the central nervous system, gastrointestinal system, and cardiovascular system.

Career Highlights

Throughout his career, András Egyed has worked with prominent companies in the pharmaceutical industry, including Egis Gyógyszergyár Nyrt and Egis Gyógyszergyár Rt. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug development.

Collaborations

Egyed has collaborated with esteemed colleagues such as József Barkóczy and István Gacsályi. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.

Conclusion

András Egyed stands out as a significant figure in pharmaceutical innovation, with a focus on developing new treatments for critical health issues. His contributions through patents and collaborations continue to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…